Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Data Collection × Dermatologic × Clear all

Status

Unknown 1 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Other hematologic neoplasm 1 Lymphoid 1 Dermatologic 1 Breast 1

Conditions

Uveal Melanoma 1

Interventions

pembrolizumab 67 Nivolumab 44 Ipilimumab 26 Specimen Handling 13 trametinib 12 Magnetic Resonance Spectroscopy 12 Cyclophosphamide 11 Biopsy 10 dabrafenib 9 Radiotherapy 9 avelumab 8 Radiosurgery 8 fludarabine 7 cemiplimab 7 atezolizumab 7 CTLA-4 Antigen 7 lenvatinib 6 durvalumab 6 Interleukin-2 6 Immunoglobulin G 6 Disulfides 6 fludarabine phosphate 5 encorafenib 5 dostarlimab 5 binimetinib 5 Carboplatin 5 Bevacizumab 5 tislelizumab 4 cobimetinib 4 Paclitaxel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06432660 2026-02-06

PROMPT

Duke University

Active not recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡